PILOT AND FEASIBILITY PROGRAM
PILOT AND FEASIBILITY PROGRAM
批准号:
6612298
负责人:
JEFFREY A BLUESTONE
金额:
$7.57万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-01 至 2007-08-31
关键词:
NOD mouse T cell receptor T lymphocyte autoimmunity bioenergetics cell differentiation diabetes mellitus genetics diabetes mellitus therapy disease /disorder model gene expression genetic models health science research support hematopoietic stem cells imaging /visualization /scanning immunity insulin dependent diabetes mellitus laboratory mouse leukocyte activation /transformation natural killer cells neurons noninsulin dependent diabetes mellitus obesity pancreatic islets pathologic process technology /technique development
中文摘要
描述(由申请人提供):
加州大学旧金山分校糖尿病中心试点和可行性(P&F)计划于18个月前建立,旨在
鼓励追求高度新颖的研究,以了解和治疗1型和2型
糖尿病。该计划面向加州大学旧金山分校社区的所有成员--糖尿病中心的现有教员以及来自加州大学旧金山分校其他部门和研究所的其他调查人员--以利用该机构内与糖尿病相关的许多和不同的机会。加州大学旧金山分校实施的P&F计划为研究人员提供两年的支持,每年2.5万美元,以支持概念性创新研究。同样重要的是,这些奖项希望提供种子资金,以产生足够的数据,通过其他资助机制开展更多的研究工作。
DRTC P&F计划将致力于:1.促进和允许新的研究人员和初级教员建立糖尿病研究计划;2.促进和支持希望将技能和研究发展转移到糖尿病研究领域的现有教员;3.促进基础和临床糖尿病研究的高度创新方向,包括少数族裔和其他服务不足的患者群体的临床研究;以及4.促进DRTC UCSF教职员工之间的新的和创新的合作。试点和可行性计划委员会将由道格拉斯·哈纳汉博士担任主席,委员会成员包括格罗德格罗德斯基博士、迈克尔·德尔曼博士和艾拉·戈德费恩博士。作为一个小组,该委员会代表了中心的所有方面,以协助主任管理方案。
英文摘要
DESCRIPTION (provided by the applicant):
The UCSF Diabetes Center Pilot & Feasibility (P&F) Program was established 18 months ago to
encourage the pursuit of highly novel research for understanding and treating type 1 and type 2
diabetes. The program has been targeted towards all members of the UCSF community - the existing faculty of the Diabetes Center as well as other investigators from other departments and institutes at UCSF - in order to capitalize on the many and varied opportunities within the institution that have pointed relevance to diabetes. The P&F program implemented at UCSF provides investigators with two years of support at $25,000 per year to support conceptually innovative studies. As importantly, these awards are hoped to provide seed funding that will generate sufficient data to pursue additional research efforts through other funding mechanisms.
The DRTC P&F Program will endeavor to: 1. facilitate and allow new investigators and junior faculty to establish research programs in diabetes; 2. facilitate and support established faculty wishing to transfer skills and research developments to the arena of diabetes research; 3. foster highly innovative directions in basic and clinical diabetes research, including clinical studies in minority and other underserved patient groups; and 4. foster new and innovative collaborations amongst DRTC UCSF Faculty. The Pilot & Feasibility Program committee is will be chaired by Dr. Douglas Hanahan and the Committee includes Drs. Gerold Grodsky, Michael German and Ira Goldfine. As a group this committee represents all the aspects of the Center to assist the director in the management of the program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Designer Tregs for restoring tolerance in patients with type 1 diabetes
-
批准号:9459191
-
项目类别:
-
资助金额:$335.17万
-
财政年份:2017
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Project 2 - Specificity and repertoire of Tregs in T1D
-
批准号:9151389
-
项目类别:
-
资助金额:$40.87万
-
财政年份:2016
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation
-
批准号:8672260
-
项目类别:
-
资助金额:$98.32万
-
财政年份:2014
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Role of Innate Lymphoid Cells in Autoimmunity
-
批准号:8637675
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2013
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"
-
批准号:8728396
-
项目类别:
-
资助金额:$5.72万
-
财政年份:2012
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"
-
批准号:8264452
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2012
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Spontaneous Autoimmune Model of Peripheral Neuropathy
-
批准号:8116742
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Expanding beta-cell mass"
-
批准号:7994038
-
项目类别:
-
资助金额:$118.56万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Expanding beta-cell mass"
-
批准号:8322756
-
项目类别:
-
资助金额:$130.15万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
"Expanding beta-cell mass"
-
批准号:8143503
-
项目类别:
-
资助金额:$130.15万
-
财政年份:2010
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity
-
批准号:7688822
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2009
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Islet Core
-
批准号:7510118
-
项目类别:
-
资助金额:$20.97万
-
财政年份:2007
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
CTLA-4 functions in tolerance and autoimmunity
-
批准号:7215474
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2006
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Flow Cytometry
-
批准号:7215480
-
项目类别:
-
资助金额:$24.05万
-
财政年份:2006
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Role of Notch 1 in Immune Tolerance
-
批准号:6782125
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2004
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Role of Notch 1 in Immune Tolerance
-
批准号:6876102
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2004
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Islet Metabolism Core
-
批准号:7925411
-
项目类别:
-
资助金额:$21.26万
-
财政年份:2003
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
Diabetes Research and Training Center
-
批准号:6584737
-
项目类别:
-
资助金额:$117.83万
-
财政年份:2003
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
CORE--ISLET PRODUCTION
-
批准号:6612293
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2002
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
CORE--MOUSE GENETICS
-
批准号:6612294
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2002
-
负责人:JEFFREY A BLUESTONE
-
依托单位:
国内基金
海外基金
T-cell Receptor信号通路调控基因的表达机制分子解析
-
批准号:32570839
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:范高峰
-
依托单位: